BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34271024)

  • 21. Cell Culture Characterization of Prooxidative Chain-Transfer Agents as Novel Cytostatic Drugs.
    Heymans V; Kunath S; Hajieva P; Moosmann B
    Molecules; 2021 Nov; 26(21):. PubMed ID: 34771157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
    Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
    BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
    Kassab AE; Hassan RA
    Bioorg Chem; 2018 Oct; 80():531-544. PubMed ID: 30014921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 4β-amidotriazole linked podophyllotoxin congeners: DNA topoisomerase-IIα inhibition and potential anticancer agents for prostate cancer.
    Reddy VG; Bonam SR; Reddy TS; Akunuri R; Naidu VGM; Nayak VL; Bhargava SK; Kumar HMS; Srihari P; Kamal A
    Eur J Med Chem; 2018 Jan; 144():595-611. PubMed ID: 29289884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines.
    Buzharevski A; Paskas S; Sárosi MB; Laube M; Lönnecke P; Neumann W; Mijatovic S; Maksimovic-Ivanic D; Pietzsch J; Hey-Hawkins E
    ChemMedChem; 2019 Feb; 14(3):315-321. PubMed ID: 30602073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and in vitro antitumour activity of 4(R)-methyl-3-O-phosphonomethyl-α-l-threose nucleosides.
    Liu FW; Ji S; Gao Y; Meng Y; Xu W; Wang H; Yang J; Huang H; Herdewijn P; Wang C
    Eur J Med Chem; 2021 Oct; 221():113513. PubMed ID: 34000485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage.
    Ha K; Fiskus W; Rao R; Balusu R; Venkannagari S; Nalabothula NR; Bhalla KN
    Mol Cancer Ther; 2011 Jul; 10(7):1194-206. PubMed ID: 21566061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells.
    Serova M; Calvo F; Lokiec F; Koeppel F; Poindessous V; Larsen AK; Laar ES; Waters SJ; Cvitkovic E; Raymond E
    Cancer Chemother Pharmacol; 2006 Apr; 57(4):491-9. PubMed ID: 16075278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Cytostatic Ruthenium(II)-Platinum(II) Bis(terpyridyl) Anticancer Complex That Blocks Entry into S Phase by Up-regulating p27(KIP1).
    Ramu V; Gill MR; Jarman PJ; Turton D; Thomas JA; Das A; Smythe C
    Chemistry; 2015 Jun; 21(25):9185-97. PubMed ID: 25950156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status.
    Altaf M; Monim-Ul-Mehboob M; Kawde AN; Corona G; Larcher R; Ogasawara M; Casagrande N; Celegato M; Borghese C; Siddik ZH; Aldinucci D; Isab AA
    Oncotarget; 2017 Jan; 8(1):490-505. PubMed ID: 27888799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATM-dependent CHK2 activation induced by anticancer agent, irofulven.
    Wang J; Wiltshire T; Wang Y; Mikell C; Burks J; Cunningham C; Van Laar ES; Waters SJ; Reed E; Wang W
    J Biol Chem; 2004 Sep; 279(38):39584-92. PubMed ID: 15269203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RO3280: A Novel PLK1 Inhibitor, Suppressed the Proliferation of MCF-7 Breast Cancer Cells Through the Induction of Cell Cycle Arrest at G2/M Point.
    Ergul M; Bakar-Ates F
    Anticancer Agents Med Chem; 2019; 19(15):1846-1854. PubMed ID: 31244432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiproliferative and antimetastatic characterization of an exo-heterocyclic androstane derivative against human breast cancer cell lines.
    Kulmány ÁE; Frank É; Kovács D; Kirisits K; Krupitza G; Neuperger P; Alföldi R; Puskás LG; Szebeni GJ; Zupkó I
    Biomed Pharmacother; 2021 Aug; 140():111728. PubMed ID: 34020244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor.
    Yaguchi S; Fukui Y; Koshimizu I; Yoshimi H; Matsuno T; Gouda H; Hirono S; Yamazaki K; Yamori T
    J Natl Cancer Inst; 2006 Apr; 98(8):545-56. PubMed ID: 16622124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
    Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA
    Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chk1, but not Chk2, is involved in the cellular response to DNA damaging agents: differential activity in cells expressing or not p53.
    Carrassa L; Broggini M; Erba E; Damia G
    Cell Cycle; 2004 Sep; 3(9):1177-81. PubMed ID: 15326376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic effects of exemestane and aspirin on MCF-7 human breast cancer cells.
    Hu LX; Du YY; Zhang Y; Pan YY
    Asian Pac J Cancer Prev; 2012; 13(11):5903-8. PubMed ID: 23317278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
    Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
    Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and Biological Evaluation of Novel Triazoles Linked 7-hydroxycoumarin as Potent Cytotoxic Agents.
    Farooq S; Hussain A; Qurishi MA; Hamid A; Koul S
    Anticancer Agents Med Chem; 2018; 18(11):1531-1539. PubMed ID: 29298653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary metabolites from a culture of the fungus Neosartorya pseudofischeri and their in vitro cytostatic activity in human cancer cells.
    Eamvijarn A; Kijjoa A; Bruyère C; Mathieu V; Manoch L; Lefranc F; Silva A; Kiss R; Herz W
    Planta Med; 2012 Nov; 78(16):1767-76. PubMed ID: 22976482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.